Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05048667Phase 1Completed
Phase 1, randomised, double-blind trial in erectile dysfunction (ED) comparing SWT plus PRP Group with Sham SWT plus Placebo Saline Group (2 arms). Primary endpoint: Number of Participants With Treatment Emergent Serious Adverse Events at Month 3. Started Jun 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05048667.